Bridgewater Associates’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,928
Closed -$620K 789
2024
Q3
$620K Sell
4,928
-5,449
-53% -$685K ﹤0.01% 667
2024
Q2
$1.12M Sell
10,377
-1,077
-9% -$105K 0.01% 641
2024
Q1
$1.08M Sell
11,454
-1,852
-14% -$175K 0.01% 564
2023
Q4
$1.23M Sell
13,306
-1,460
-10% -$112K 0.01% 607
2023
Q3
$945K Buy
14,766
+1,202
+9% +$77K 0.01% 618
2023
Q2
$839K Sell
13,564
-2,989
-18% -$177K 0.01% 599
2023
Q1
$961K Buy
16,553
+620
+4% +$35.6K 0.01% 567
2022
Q4
$948K Sell
15,933
-5,657
-26% -$343K 0.01% 650
2022
Q3
$1.37M Buy
21,590
+28
+0.1% +$1.95K 0.01% 636
2022
Q2
$1.51M Buy
21,562
+3,435
+19% +$241K 0.01% 733
2022
Q1
$1.27M Buy
18,127
+4,369
+32% +$294K 0.01% 772
2021
Q4
$935K Sell
13,758
-1,711
-11% -$118K 0.01% 587
2021
Q3
$1.08M Sell
15,469
-381
-2% -$27.7K 0.01% 504
2021
Q2
$1.11M Buy
+15,850
New +$1.15M 0.01% 566

Other funds holding NHC

Bridgewater Associates's NHC Position: Q4 2024 in Review

Bridgewater Associates sold out of National Healthcare (NHC) in Q4 2024, closing a stake of 4,928 shares — an estimated $620K sold.

Bridgewater Associates first reported a position in NHC in Q2 2021 and held it in 14 quarters. The position peaked at $1.51M in Q2 2022. 185 funds tracked by Wall St. Rank hold NHC as of Q4 2024.

  • Bridgewater Associates reported no remaining National Healthcare position as of Q4 2024 after selling out during the quarter.
  • Bridgewater Associates sold 4,928 National Healthcare shares in Q4 2024, an estimated $620K.
  • Bridgewater Associates first reported a position in National Healthcare in Q2 2021 and held it in 14 quarters.
  • Bridgewater Associates's National Healthcare position peaked at $1.51M in Q2 2022.
  • 185 funds tracked by Wall St. Rank held National Healthcare as of Q4 2024.

Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.